Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 80Active not recruiting 42Not yet recruiting 22Completed 11Terminated 4Withdrawn 2Suspended 1Enrolling by invitation 1Available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Lymphoid 1Gynecologic 1Endocrine 1

Conditions

Glioblastoma 10Breast Neoplasms 10Neoplasms 9Leukemia, Myeloid, Acute 9Neoplasm Metastasis 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Prostatic Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Myelodysplastic Syndromes 5Lung Neoplasms 5Hematologic Neoplasms 5Ovarian Neoplasms 4Multiple Myeloma 4Glioma 4Uterine Cervical Neoplasms 3Sarcoma 3Melanoma 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Astrocytoma 3Triple Negative Breast Neoplasms 2Solid Tumors 2Solid Tumor 2Recurrence 2Rectal Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Osteosarcoma 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Small Cell Lung Carcinoma × 90 days × Clear all
NCT05337735 2026-05-04

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

M.D. Anderson Cancer Center

Phase 2 Suspended
140 enrolled
EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡